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  lport Syndrome (AS) is an important hereditary disorder affecting the glomerular basement membrane. Diagnosis of AS is
based on the presence of hematuric nephropathy, renal failure, hearing loss, ocular abnormalities and changes in the glomerular
basement membrane of the lamina densa. The aims of this case report were to show the changes in the gingival tissues in a patient
with AS under therapy with cyclosporin-A after renal transplantation and to discuss the possible role of type IV collagen in gingival
basal lamina as an alternative approach for the diagnosis of AS. A 20-year-old male patient with AS underwent periodontal therapy
including a series of gingivectomy surgeries. Gingival samples obtained during the second surgery were examined histopathologically
and by transmission electron microscopy for further pathological examination. Gingivectomy procedures have been performed
every 6 months over the last 4 years. The excessive and fibrous gingival enlargements resulted in migration of the anterior teeth, but
no alveolar bone loss occurred. This is the first report to demonstrate the possible changes in the gingival tissues caused by AS. It is
suggested that gingival biopsy can be an initial diagnostic tool instead of renal or skin biopsies. Proper dental and periodontal care
and regular visits to the dentist could provide limited gingival hyperplasia to patients with AS.
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INTRODUCTION
Alport Syndrome (AS) was first described in 1927 as a
hereditary disorder characterized by a combination of
nephritis and deafness1. This syndrome is a basement
membrane (BM) disease affecting approximately 1 in every
5,000 people7. The disease manifests with juvenile to adult
onset progressive glomerulonephritis usually associated
with a high-frequency-specific sensorineural hearing loss,
dot and fleck retinopathy, and lens abnormalities12. Two
forms have been recognized in the molecular genetic base
of AS. The dominant X-linked form owing to mutations of
locus COL4A5 and the recessive autosomal form resulting
from mutations to loci COL4A3 or COL4A43. However,
the genealogical analysis suggests a dominant autosomal
type. Although approximately 85% of the cases are X-
linked dominant form there is also a recessive autosomal
form for about 15%. Family history is negative in isolated
cases of de novo mutation.
Type IV collagen is the main component of the basal
membrane. The mutation presented in AS produces defects
in chains α3, α4, and α5(IV). Type IV collagen damage,
owing to mutation, breaks the epithelial bonds and leads
to an organ defect14. These defects in chains result in
entanglement and incorrect set-up of monomers which are
quickly degraded. These mutations interrupt the normal
replacement of the embryonic development and cause
persistence of chains α1.α1 α2(IV) in renal basal
membranes, cochlea and capsule of lenses.
The main structural and fibrilar component of the
human gingival connective tissue is collagen, which
accounts for about 60% of the total tissue protein. Previous
biochemical studies have demonstrated that type IV
collagen accounts for less than 1% of the total collagenous
component of the healthy human gingival connective
tissue20. Type IV collagen is presented at the BM of the
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human gingiva, which separates the connective tissue from
the epithelium.
The clinical presentation of the syndrome emerges with
signs such as; hematuria, progressive renal failure,
sensorineural hearing loss (SNHL) (variable intensity,
bilateral, symmetrical and progressive; present in
approximately 55% of men and 45% of women), ocular
affections, (anterior lenticonus, ocular stains and
cataracts4), macro-thrombocytopenia23 and
leiomyomatosis27.
Hearing loss is one of the initial and most common
sign in a patient with hematuria. SNHL in high frequencies
suggests AS even in the absence of renal biopsy or family
history of renal failure. It is generally accepted that the
initial approach to a patient with clinical features and
positive family history of AS is skin biopsy and the
presence of α5 collagen chain in the skin leads to renal
biopsy16. Renal biopsy may be risky in cases of renal
failure11,16,17,23,27. Careful follow-up of the hearing loss is a
relevant factor of the prognosis of the renal disease
progression. Men with hearing loss in the first two decades
of life have more severe renal diseases11. The regular
assessment of hearing in a patient with AS is very
important. Ocular abnormalities in these patients hinder
visual clues which are essential for the communication with
the patient who has severe hearing loss.
Dialysis and renal transplantation are indicated in this
group of patients with AS and end-stage renal failure12,17.
Immunosuppressant drugs, cyclosporin-A (CsA) and
corticoids are administered to patients who undergo renal
transplantation. The prognosis improves with renal
transplantation increasing longevity of the patient with AS
and renal failure12.
The aims of this case report are to show the changes in
the gingival tissues in a patient with AS under therapy with
cyclosporin-A after renal transplantation and to discuss the
possible role of type IV collagen in gingival basal lamina
as an alternative approach for the diagnosis of AS.
CASE REPORT
Case Description and Gingival Surgery
In 2003, a 20-year-old male patient was referred to the
Baskent University, Faculty of Dentistry,  Department of
Periodontology, Ankara, Turkey for treatment of severe
gingival hyperplasia. The patient’s persistent
microhematuria was discovered when he was 3 years old
during a routine pediatric examination. While he had
temporary bilateral hearing loss, no abnormalities were
seen in the optical media, specifically no cataract or
lenticonus. There was no family history. He had a renal
biopsy at the University of Heidelberg in Germany and he
was diagnosed as having AS. His family history was also
negative to de novo mutation.
Review of medical history revealed that at the age of
16, the patient started a regular hemodialysis regimen due
to the end-stage renal disease. He was scheduled for renal
transplantation and was put under an immunosuppressive
protocol in the meantime. The patient received a kidney
from his mother and, after the transplantation,
immunosuppressant drugs - cyclosporin-A (5 mg/kg/day),
prednisolone (15 mg/kg/day) and azathioprine (2 mg/kg/
day) - were prescribed for prevention of transplant
rejection. His postoperative healing period was uneventful
and he had a good renal function with creatinine levels
ranging from 0.9 to 2.9 mg/dL at present. No rejection
episode was occurred.
He had progressive and symmetrical SNHL hearing
loss, mainly affecting high frequency ranges (>2,000 Hz).
He had bilateral cochlear implants for the rehabilitation
of hearing function. At the age of 22, bilateral visual failure
began because of a large myopic shift. On the
ophthalmologic examination, his visual acuity was 20/100
with -4.00 (-4.50*120) in the right eye and 20/70 with -
4.25 (-2.50*170) in the left eye. The ocular surface, cornea
and anterior chamber were normal. Slit lamp examination
revealed anterior lenticonus in both eyes. Both lenses were
clear with no evidence of cataract. Fundus examination
was normal in both eyes. Right eye underwent a clear lens
phacoemulsification surgery and intraocular lens
FIGURE 1- Gingival enlargement affecting the buccal (A) and palatal (B) surfaces of all teeth
A B
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implantation. After the surgery, visual acuity increased to
20/30 with +0.50(-2.00*10) in right eye. Similar procedure
has planned for the left eye.
One year after renal transplantation, the patient started
complaining of gingival enlargement affecting both buccal
and lingual/palatal surfaces of all teeth (Figure 1). Although
his oral hygiene was poor, he had no decayed or missing
teeth. Gingival enlargement treatment started with oral
hygiene instructions and scaling and root planning. First
gingivectomy surgery was performed at the anterior regions
of both maxilla and mandible with antibiotic prophylaxis
(2 g amoxicillin/30 min before surgery), to recover esthetic.
Two weeks later, gingivectomy was performed in all
posterior regions. Wound healing was uneventful (Figure
2). Four months later, however, recurrence of gingival
enlargement was observed at all gingival sites. Gingival
biopsy was taken for histopathological analysis by light
microscopy and immunohistochemistry and examination
by transmission electron microscopy (TEM).
For histopathological analysis, gingival biopsies were
done and the specimens were fixed in 10% formalin
solution and embedded in paraffin blocks after routine
processing. Then, 4-5-μm-thick sections were obtained and
stained with hematoxylin and eosin (HE). Microscopic
examination of the HE-stained slides showed epithelial
hyperplasia and fibrosis. Serial sections were
immunostained with a biotin-streptavidin complex system
(ACE+ Substrate chromogene Ready to Use, K3469,
DAKO, Denmark ) for type IV collagen (Clone CIV 22,
Nr. M 0785 USA) and the basal membrane under the
squamous epithelium was observed on some sites with
discontinuity (Figure 4).
For TEM analysis, the gingival specimens were fixed
in phosphate-buffered saline containing 2.5%
glutaraldehyde for 2-3 h, post-fixed in 1% osmium
tetroxide and dehydrated in a series of increasing ethanol
concentrations (25%, 50%, 75%, 95%, and absolute
alcohol). After passing through propylene oxide, the
specimens were embedded in quick-setting epoxy resin
(Araldite CY 212, Ciba-Geigy, Basel, Switzerland) DDSA
(2-dodecenyl succinic anhydride), BDMA
(benzyldimethylamine) and dibutylphtalate. Semithin
sections were obtained and stained with blue toluidin and
examined with a light microscope. Ultrathin sections were
FIGURE 2- Gingivectomy performed at the buccal (A) and lingual (B) surfaces
A B
FIGURE 3- Migration of anterior teeth due to excessive and fibrous gingival enlargement, though without alveolar bone loss
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stained with uranyl acetate and lead citrate and examined
with LEO 906E EM transmission electron microscope
(Zeiss, Jena, Germany). There was tonofilament
accumulation in most epithelial basal cells (Figure 5). The
lamina densa was disrupted in several regions (Figures 6
and 7) and hemidesmosoms remained intact (Figure 8).
Dense bundles of thick collagen fibers were organized
around and under the BM (Figure 9).
In order to protect the patient from the side effects of
CsA therapy on the gingiva tissues, the patient was referred
to the Nephrology Department for consultation. However,
the nephrologist pointed out that the patient had an
aggressive course of AS and that, since control of the
disease was accomplished successfully with CsA, he was
not willing to change the medication.
FIGURE 4- Epithelial hyperplasia and fibrosis observed
under light microscopy and immunohistochemistry with type
IV collagen staining. Basal membrane under the squamous
epithelium is observed on some sites with discontinuity
(arrows) (x400)
FIGURE 5- TEM micrograph showing tonofilament clumping
(arrow) (x27800)
FIGURE 6- TEM micrograph showing basement membrane
(lamina densa; darker line, lamina lucida; lighter line) and
tonofilaments (x46460)
FIGURE 7- TEM micrograph showing disrupted (white arrow)
and discontinuous (black arrow) basement membrane
(x35970)
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Gingivectomy procedures have been performed every
6 months during the last 4 years. The excessive and fibrous
gingival enlargements resulted in migration of the anterior
teeth, but no alveolar bone loss occurred (Figure 3).
DISCUSSION
AS is a hereditary disorder characterized by hematuric
nephritis leading to an end-stage renal disease, sensory-
neural deafness and ocular abnormalities. AS have been
attributed to the production of a defective type IV collagen21.
Type IV collagen is the main component of the glomerular
BM and composed of six genetically distinct chains, namely
α1(IV) - α6(IV), encoded by gene pairs located on three
different chromosomes10,20,26.
Renal transplantation has proven to be the best treatment
for patients with an end-stage renal disease18,24. It is generally
successful in patients with AS but in cases where graft loss
occurs, re-transplantation usually fails. CsA has been shown
to be effective at halting the progression of renal failure in
AS2. CsA is a cyclic polypeptide with potent and selective
immunosuppressive activity, acting primarily by inhibiting
interleukin-2 gene transcription in CD4+ lymphocytes6. CsA
treatment is associated with side effects including chronic
nephrotoxicity30, hepatotoxicity9 and neurotoxicity3,
hypertention27,28 and gingival overgrowth5.
The patient of this case received a kidney from his mother
and was put in an immunosuppressive drug regimen with
CsA (5 mg/kg/d), prednisolone (15 mg/kg/d), and
azathioprine (2 mg/kg/d). The prednisolone dose was
gradually reduced to 10 mg/kg/d. The relationship between
CsA and the development of gingival overgrowth is well
established in humans as well as in animal experimental
models5,8. Gingival enlargement, occurring in a range of 25-
81% of the patients, is a severe pathology that interferes
with normal oral functions such as mastication and speech,
and causes profound psychological problems to the patients8.
Hyland, et al.15 (2003) recently suggested that since less 50%
of the patients taking CsA develop gingival overgrowth, a
genetic predisposing may explain the different responses of
gingival fibroblasts in collagen turnover regulation after CsA
treatment and may play a major role in the pathogenesis of
CsA-induced overgrowth. Other factors such as the influence
of different pre-existing gingival conditions (e.g. gingival
inflammation) and the different host’s capacity to deal
metabolically with CsA should also be considered as they
might affect CsA-induced pathogenesis8.
Collagen comprises more than 60% of the periodontal
tissues. The basal lamina, which is largely composed of
glycoproteins (laminin and nidogen), collagen type IV, and
proteoglycans, underlies the oral epithelium and forms a
barrier between the epithelium and the connective tissue.
Interactions between epithelial cells and fibroblasts stimulate
type IV collagen and laminin expression in epithelial cells
in vitro25. Type IV collagen was observed
immunohistochemically underneath the basal epithelial
cells29. These molecules are important in epithelium
formation and they establish the junctional seal separating
the oral cavity from the interstitial environment. A
breakdown of this seal is a significant factor in periodontal
disease development and its reformation is required for
successful periodontal treatment or periodontal
FIGURE 8- TEM micrograph showing intact hemidesmozoms
(arrows) (x35970)
FIGURE 9- TEM micrograph showing collagen fibers
organized parallel bundles under the basement membrane
(x16700)
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regeneration21. AS is caused by defects in type IV collagen,
which is the major component of BM. It is generally accepted
that the initial approach for patients with the clinical features
and a sustaining family history of AS is skin biopsy. In the
presence of the α5 collagen chain in the skin, next approach
would be a renal biopsy25. The typically thin glomerular BM
thickens over time into multilamellations surrounding lucent
areas that often contain granules of varying densities13.
The diagnostic value of skin biopsy has first described
in 1986 since a kidney biopsy could be risky in cases of
renal failure22. Skin biopsy is especially useful if a kidney
biopsy poses an excessive risk, as in the patients with an
end-stage renal disease. While the α5 chain of type IV
collagen is also expressed in epidermis, an
immunofluorescence examination of skin biopsy specimen
can be used to establish the diagnosis. Approximately 80%
of male patients and 60% of female patients with X-linked
AS have no α5(IV) collagen in epidermal BM. In addition,
most individuals with autosomal recessive AS do not express
α3(IV), α4(IV), or α5(IV) collagens in skin. Healthy
individuals and patients with thin-membrane disease have
normal expression of α5(IV) in the skin. Hamiwka, et al.13
(2007) suggested that when a kidney biopsy is considered
necessary in a female patient with persistent hematuria but
without a clear family history of AS or proteinuria, renal
biopsy alone may not be enough to exclude AS carrier status.
A skin biopsy obtained at the time of the kidney biopsy
should not pose any further risk for the patient but can
provide some additional information.
Could gingiva, which has type IV collagen in it is BM
be valuable for the diagnosis of AS? In this report,
immunohistochemical analysis revealed disrupted areas on
the BM. These findings were supported by TEM analysis,
which showed that the lamina densa was disrupted in several
regions of the BM. In the gingival tissue, the basal lamina is
largely composed by collagen type IV. The reason of these
irregularities and disruptions might have been arisen from
type IV collagen.
Gingival biopsy is easily done under local anesthesia,
and tissue specimens that are obtained from the intraoral
region do not cause esthetic problems.
In addition to having AS, our patient was an organ
transplant recipient and under immunosuppressive therapy
with CsA. The effects of CsA on gingiva have been
recognized but not many studies have discussed the effects
of CsA on type IV collagen are available. Mondella, et al.19
(1994) evaluated the BM changes in a group of patients
with psoriasis and consuming CsA. In the patients with
discontinuous staining of type IV collagen, evident and
continuous staining of type IV collagen within the BM was
observed after the CsA treatment.
The results of the present case indicates that when the
effect of CsA on the repair of the continuity of type IV
collagen in the BM is considered, despite the CsA therapy,
the continuing irregularity and discontinuity in the basal
lamina increases the possibility of gingival type IV collagen
defects in the patients with AS.
There is no evidence about the possible changes that AS
causes in the gingival tissues. Therefore the precise
evaluation of the effects of CsA on the gingival tissues of
the patients with AS is not possible. Future studies should
evaluate the effects of AS on type IV collagen in gingiva
and the influence of CsA, which has an important role in AS
both pre and post-transplantation, on the gingival collagen.
Patients with AS and renal failure have their prognosis
improved and their longevity increased with renal
transplantation. Therefore, the follow up, rehabilitation, and
investigation of the progression of hearing loss and
ophthalmological problems become important in the quality
of life of these patients. Maintenance of good oral hygiene
with regular visits to the dentist can limit gingival
hyperplasia. As in all patients under immunosuppressive
treatment, prevention of infection is also very important for
patients with AS. CsA has a determinant role before and
after renal transplantation as well as on the treatment of AS,
and the side effects of this drug on gingiva are increased in
the presence of infection. Aggressive and severe gingival
hyperplasia hinders biofilm control and causes migration
of teeth. If untreated, this condition can compromise the
patients’ dental and gingival esthetics and cause nutrition
problems, and periodontal or dental infections.
In order to prolong the lifetime, alongside with regular
nephrological, ocular and hearing evaluations, periodical
examinations of the oral tissues are consequent for these
patients with a low quality of life. The possible role of
gingival biopsy, which is easier and less risky than renal or
skin biopsies, on the early diagnosis and evaluations of the
treatment results of AS should be investigated.
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